Search

everythinglearnresearchcommunity

for

Search:↓

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Ranitidine and finasteride lower TMAO levels, reducing heart and kidney damage by changing gut bacteria.

5ARIs effectively treat and manage BPH by reducing prostate size and symptoms.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

The vitamin D receptor can affect gene activity even without its usual hormone in hair and skin.

Vitamin D receptor actions without binding are crucial for healthy skin and hair.

AGA might indicate higher risk for severe COVID-19.

Brain-made chemicals can control nerve cell function differently in various parts of a mouse's brain, which may help us understand neurological conditions.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

Vitamin D receptor may help protect against UV-induced skin cancer.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Duloxetine, escitalopram, and finasteride may be effective against bacteria and fungi.

Vitamin D3 and its receptor are important for hair growth, and understanding receptors could help treat hair graying and skin cancer.

Dutasteride may protect the brain in early Parkinson's disease.

Retinoic acid receptors are important for hair follicle development.

Vitamin D receptor helps prevent skin cancer and supports skin health.

GFRα2 is essential for controlling neuron size but not for target innervation in certain sensory neurons.

Venlafaxine can cause urinary incontinence in rare cases.

Most Hairless gene mutations reduce its ability to work with the Vitamin D Receptor, which might explain a certain type of hair loss.

GnRH treatment can reduce breast cancer cell invasion.

Low-dose naltrexone may help reduce redness in certain scalp conditions.

Non-liganded Vitamin D Receptor is crucial for healthy skin and hair.

Fexofenadine reduces discomfort but doesn't significantly improve hair regrowth in Alopecia Areata treatment.

AHR ligands could treat inflammatory skin diseases.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

These medications for BPH have known risks and may have new side effects.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

A certain medication improved severe itching in a boy with liver and bowel disease by reducing histamine levels, suggesting a new treatment target.

Promising cancer treatments were found, but the manufacturer closed.